MedTrace Logo

The Effect of Acupuncture on Pulmonary Function Recovery Following Lung Resection

NCT07443540 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2026-03-02

No results posted yet for this study

Summary

Background and Purpose:

Lung resection surgery is the standard treatment for early-stage lung adenocarcinoma, but it often leads to reduced lung volume and postoperative pain, which can hinder pulmonary recovery. While standard rehabilitation includes breathing exercises (incentive spirometry) and pain management, additional strategies are needed to enhance recovery. Acupuncture has shown benefits in managing respiratory diseases like COPD and reducing surgical pain, but its specific effectiveness in rehabilitation after lung resection has not yet been established. This study aims to evaluate whether adding acupuncture to standard postoperative care can further improve lung function and recovery.

Study Design and Methods:

This is a randomized controlled clinical trial. Participants who have undergone lung resection will be assigned to one of two groups:

Control Group: Receives standard rehabilitation (lung volume training with incentive spirometry).

Intervention Group: Receives standard rehabilitation plus acupuncture therapy.

Evaluation:

One week after surgery, researchers will perform pulmonary function tests on all participants. The study will compare the two groups primarily based on improvements in lung function. Secondary outcomes, including pain levels and quality of life, will also be assessed to determine the overall benefit and safety of integrating acupuncture into postoperative recovery.

Conditions

  • Lung Nodules

Interventions

PROCEDURE

Acupuncture Therapy

Acupuncture will be administered by certified practitioners.

DEVICE

Incentive Spirometry (Standard Rehabilitation)

Postoperative lung volume training using an incentive spirometer. Participants are instructed to perform deep breathing exercises multiple times a day as per current clinical guidelines for lung resection recovery.

Sponsors & Collaborators

  • Chung Shan Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2026-12-30
Completion
2027-01-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07443540 on ClinicalTrials.gov